SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-006061
Filing Date
2021-03-30
Accepted
2021-03-30 07:16:55
Documents
14
Period of Report
2021-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K pirs-20210329.htm   iXBRL 8-K 37050
  Complete submission text file 0001628280-21-006061.txt   188987

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20210329.xsd EX-101.SCH 2459
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20210329_cal.xml EX-101.CAL 745
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20210329_def.xml EX-101.DEF 1691
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20210329_lab.xml EX-101.LAB 26285
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20210329_pre.xml EX-101.PRE 13763
7 EXTRACTED XBRL INSTANCE DOCUMENT pirs-20210329_htm.xml XML 11989
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 21783611
SIC: 2834 Pharmaceutical Preparations